Addition of low-dose sufentanil to ropivacaine for reducing shivering and visceral traction pain during cesarean section

Objective To investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal anesthesia. Methods This was a prospective, randomized, controlled study. A total of 112 full-term parturients who underwent elective caesarean delive...

Full description

Saved in:
Bibliographic Details
Published inJournal of international medical research Vol. 49; no. 5; p. 3000605211017000
Main Authors Chen, Xiao-Rong, Gao, Tao, Zhang, Yin, Peng, Ming-Qing
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.05.2021
Sage Publications Ltd
SAGE Publishing
Subjects
Online AccessGet full text
ISSN0300-0605
1473-2300
1473-2300
DOI10.1177/03000605211017000

Cover

Abstract Objective To investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal anesthesia. Methods This was a prospective, randomized, controlled study. A total of 112 full-term parturients who underwent elective caesarean delivery were randomly divided into two groups. Group R received 0.75% isobaric ropivacaine intrathecally and group RS received 0.75% isobaric ropivacaine plus 5 µg sufentanil intrathecally. Results There were no significant differences in the maximum sensory block time, motor block time, duration of the surgery, and heart rate, mean arterial pressure, and blood oxygen saturation before and 1, 5, and 10 minutes after spinal anesthesia, and at the end of the surgery between the two groups. Shivering was significantly more common in group R (n = 30) than in group RS (n = 8). The incidence of visceral traction pain in group R (46.43%) was significantly higher than that in group RS (14.29%). There was no significant difference in the newborns’ Apgar scores between the groups. Conclusion Adding low-dose sufentanil to ropivacaine can significantly reduce the incidence of shivering and visceral traction pain after spinal anesthesia.
AbstractList Objective To investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal anesthesia. Methods This was a prospective, randomized, controlled study. A total of 112 full-term parturients who underwent elective caesarean delivery were randomly divided into two groups. Group R received 0.75% isobaric ropivacaine intrathecally and group RS received 0.75% isobaric ropivacaine plus 5 µg sufentanil intrathecally. Results There were no significant differences in the maximum sensory block time, motor block time, duration of the surgery, and heart rate, mean arterial pressure, and blood oxygen saturation before and 1, 5, and 10 minutes after spinal anesthesia, and at the end of the surgery between the two groups. Shivering was significantly more common in group R (n = 30) than in group RS (n = 8). The incidence of visceral traction pain in group R (46.43%) was significantly higher than that in group RS (14.29%). There was no significant difference in the newborns’ Apgar scores between the groups. Conclusion Adding low-dose sufentanil to ropivacaine can significantly reduce the incidence of shivering and visceral traction pain after spinal anesthesia.
To investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal anesthesia.OBJECTIVETo investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal anesthesia.This was a prospective, randomized, controlled study. A total of 112 full-term parturients who underwent elective caesarean delivery were randomly divided into two groups. Group R received 0.75% isobaric ropivacaine intrathecally and group RS received 0.75% isobaric ropivacaine plus 5 µg sufentanil intrathecally.METHODSThis was a prospective, randomized, controlled study. A total of 112 full-term parturients who underwent elective caesarean delivery were randomly divided into two groups. Group R received 0.75% isobaric ropivacaine intrathecally and group RS received 0.75% isobaric ropivacaine plus 5 µg sufentanil intrathecally.There were no significant differences in the maximum sensory block time, motor block time, duration of the surgery, and heart rate, mean arterial pressure, and blood oxygen saturation before and 1, 5, and 10 minutes after spinal anesthesia, and at the end of the surgery between the two groups. Shivering was significantly more common in group R (n = 30) than in group RS (n = 8). The incidence of visceral traction pain in group R (46.43%) was significantly higher than that in group RS (14.29%). There was no significant difference in the newborns' Apgar scores between the groups.RESULTSThere were no significant differences in the maximum sensory block time, motor block time, duration of the surgery, and heart rate, mean arterial pressure, and blood oxygen saturation before and 1, 5, and 10 minutes after spinal anesthesia, and at the end of the surgery between the two groups. Shivering was significantly more common in group R (n = 30) than in group RS (n = 8). The incidence of visceral traction pain in group R (46.43%) was significantly higher than that in group RS (14.29%). There was no significant difference in the newborns' Apgar scores between the groups.Adding low-dose sufentanil to ropivacaine can significantly reduce the incidence of shivering and visceral traction pain after spinal anesthesia.CONCLUSIONAdding low-dose sufentanil to ropivacaine can significantly reduce the incidence of shivering and visceral traction pain after spinal anesthesia.
Objective To investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal anesthesia. Methods This was a prospective, randomized, controlled study. A total of 112 full-term parturients who underwent elective caesarean delivery were randomly divided into two groups. Group R received 0.75% isobaric ropivacaine intrathecally and group RS received 0.75% isobaric ropivacaine plus 5 µg sufentanil intrathecally. Results There were no significant differences in the maximum sensory block time, motor block time, duration of the surgery, and heart rate, mean arterial pressure, and blood oxygen saturation before and 1, 5, and 10 minutes after spinal anesthesia, and at the end of the surgery between the two groups. Shivering was significantly more common in group R (n = 30) than in group RS (n = 8). The incidence of visceral traction pain in group R (46.43%) was significantly higher than that in group RS (14.29%). There was no significant difference in the newborns’ Apgar scores between the groups. Conclusion Adding low-dose sufentanil to ropivacaine can significantly reduce the incidence of shivering and visceral traction pain after spinal anesthesia.
Author Chen, Xiao-Rong
Peng, Ming-Qing
Zhang, Yin
Gao, Tao
Author_xml – sequence: 1
  givenname: Xiao-Rong
  surname: Chen
  fullname: Chen, Xiao-Rong
  organization: Department of Anesthesia, University-Town Hospital of Chongqing Medical University, Chongqing, China
– sequence: 2
  givenname: Tao
  surname: Gao
  fullname: Gao, Tao
  organization: Department of Anesthesia, University-Town Hospital of Chongqing Medical University, Chongqing, China
– sequence: 3
  givenname: Yin
  surname: Zhang
  fullname: Zhang, Yin
  organization: Department of Anesthesia, University-Town Hospital of Chongqing Medical University, Chongqing, China
– sequence: 4
  givenname: Ming-Qing
  orcidid: 0000-0003-3908-2958
  surname: Peng
  fullname: Peng, Ming-Qing
  organization: Department of Anesthesia, University-Town Hospital of Chongqing Medical University, Chongqing, China
BookMark eNp9kk9v3CAQxVGVqtmk_QC9IfXSi1MwxtiXSlHUP5Ei9ZI7GsOwYeWFLdjb5tsX70aNkqg9MeK992MYOCMnIQYk5D1nF5wr9YkJxljLZM0546rUr8iKN0pUdRFOyGrRq8VwSs5y3jDW1K2s35BT0TDR8b5bkd-X1vrJx0Cjo2P8VdmYkebZYZgg-JFOkaa483sw4ANSFxNNaGfjw5rmO7_HtFQQLN37bDBBiSQwB-SuRKidDw6DGRJCoBkP4lvy2sGY8d3Dek5uv365vfpe3fz4dn11eVMZyfqpagxa2_S2bSQqa1AY3g09KiFaBZK3g3C1ra2DxigpABjIoR-cEy3yrmfinFwfsTbCRu-S30K61xG8PmzEtNaQJm9G1I2QsndNx9tONXXDgJWzB9cZ3re2VIX1-cjazcMWSzOh3HR8An2qBH-n13GvC5L3rCuAjw-AFH_OmCe9XWY2jhAwzlnXUgjBRTEX64dn1k2cUyiTWlySibbmqrj40WVSzDmh-9sMZ3r5IvrFFykZ9Sxj_ATLk5Se_fjf5MUxmWGNj_38O_AHW0_OwQ
CitedBy_id crossref_primary_10_1186_s12871_022_01596_7
crossref_primary_10_1007_s00540_023_03166_8
crossref_primary_10_1186_s12871_024_02519_4
crossref_primary_10_3389_fmed_2024_1413191
crossref_primary_10_1186_s12871_025_02895_5
crossref_primary_10_1097_FPC_0000000000000513
crossref_primary_10_2147_DDDT_S460924
Cites_doi 10.1097/FTD.0000000000000112
10.1016/S0034-7094(12)70166-6
10.1016/j.bjan.2015.05.002
10.4028/www.scientific.net/AMM.740.648
10.1097/00000539-200203000-00037
10.5812/aapm.12738
10.5812/aapm.23565
10.1111/j.1399-6576.2004.00580.x
10.1097/00000542-200205000-00007
10.1016/j.jclinane.2015.11.014
10.1111/j.1399-6576.2009.02051.x
10.1590/S0102-86502014001800010
ContentType Journal Article
Copyright The Author(s) 2021
The Author(s) 2021 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021 2021 SAGE Publications
Copyright_xml – notice: The Author(s) 2021
– notice: The Author(s) 2021 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021 2021 SAGE Publications
DBID AFRWT
AAYXX
CITATION
K9.
7X8
5PM
DOA
DOI 10.1177/03000605211017000
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
Open Access: DOAJ - Directory of Open Access Journals
DatabaseTitle CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1473-2300
ExternalDocumentID oai_doaj_org_article_43559f4816874240a0cedbf8c196dedb
PMC8161908
10_1177_03000605211017000
10.1177_03000605211017000
GroupedDBID ---
.55
.GJ
01A
0R~
29K
2WC
44B
53G
54M
5GY
5RE
5VS
7X7
8FI
8FJ
AABQO
AACKU
AAFWJ
AAGGD
AAJIQ
AAJOX
AAJPV
AAJQC
AANSI
AAPEO
AAQQG
AAQXH
AASGM
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWP
ABDWY
ABHKI
ABJNI
ABNCE
ABPGX
ABQKF
ABQXT
ABUWG
ABVFX
ABXGC
ABYTW
ACARO
ACFMA
ACFYK
ACGBL
ACGFS
ACLHI
ACROE
ADBBV
ADEIA
ADMPF
ADOGD
ADQSQ
ADTBJ
ADUKL
AECVZ
AEFTW
AENEX
AERKM
AEUHG
AEWDL
AEXFG
AFCOW
AFKBI
AFKRA
AFKRG
AFPKN
AFRWT
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AUTPY
AYAKG
BAWUL
BCNDV
BDDNI
BENPR
BPHCQ
BSEHC
BVXVI
CBRKF
CCPQU
CORYS
CQQTX
CUTAK
D-I
DC.
DF.
DIK
E3Z
EBD
EBS
EF0
EJD
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HMCUK
HYE
J8X
K.F
KQ8
L7B
MK0
O9-
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
Q1R
ROL
RPM
S01
SAUOL
SCDPB
SCNPE
SFC
SV3
TR2
TUS
UKHRP
X7M
ZE2
ZGI
AAYXX
ACHEB
CITATION
OVT
K9.
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c509t-4cedd49d645e7dce3c18b9e73367a516b3f2d2dfa4c753aa0a5b9bff36e18903
IEDL.DBID DOA
ISSN 0300-0605
1473-2300
IngestDate Wed Aug 27 01:22:42 EDT 2025
Thu Aug 21 14:33:35 EDT 2025
Fri Sep 05 07:57:25 EDT 2025
Fri Jul 25 09:10:57 EDT 2025
Tue Jul 01 05:28:57 EDT 2025
Thu Apr 24 23:01:59 EDT 2025
Sun Jun 22 05:40:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords cesarean section
spinal anesthesia
shivering
visceral traction pain
Sufentanil
pregnancy
Language English
License Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c509t-4cedd49d645e7dce3c18b9e73367a516b3f2d2dfa4c753aa0a5b9bff36e18903
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0003-3908-2958
OpenAccessLink https://doaj.org/article/43559f4816874240a0cedbf8c196dedb
PMID 34038198
PQID 2535036217
PQPubID 4451107
ParticipantIDs doaj_primary_oai_doaj_org_article_43559f4816874240a0cedbf8c196dedb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8161908
proquest_miscellaneous_2533313619
proquest_journals_2535036217
crossref_primary_10_1177_03000605211017000
crossref_citationtrail_10_1177_03000605211017000
sage_journals_10_1177_03000605211017000
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-05-01
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-01
  day: 01
PublicationDecade 2020
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: London
– name: Sage UK: London, England
PublicationTitle Journal of international medical research
PublicationYear 2021
Publisher SAGE Publications
Sage Publications Ltd
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: Sage Publications Ltd
– name: SAGE Publishing
References Berti, Danelli, Antonino 2005; 71
Zheng, Wu, Qin 2015; 8
Nelson, Rauch, Terebuh 2002; 96
de Figueiredo Locks 2012; 62
Bachmann-Mennenga, Veit, Biscoping 2005; 49
Dourado, Lins Filho, Fernandes 2016; 66
Qin, Xue 2015; 21
Chen, Qian, Fu 2010; 54
Abdollahpour, Azadi, Bandari 2015; 5
Farzi, Mirmansouri, Naderi Nabi 2017; 7
Lin, Wang, Lin 2015; 10
Wang, Xia, Feng 2016; 32
Wolfler, Salvo, Sortino 2010; 76
Khaw, Ngan Kee, Wong 2002; 94
Xu, Gao, Sheng 2015; 37
Braga Ade, Braga, Hirata 2014; 29
Dourado AD (bibr14-03000605211017000) 2016; 66
bibr16-03000605211017000
bibr7-03000605211017000
bibr13-03000605211017000
bibr3-03000605211017000
Qin M (bibr1-03000605211017000) 2015; 21
bibr12-03000605211017000
bibr2-03000605211017000
Lin HQ (bibr5-03000605211017000) 2015; 10
bibr10-03000605211017000
Berti M (bibr11-03000605211017000) 2005; 71
bibr17-03000605211017000
Zheng D (bibr4-03000605211017000) 2015; 8
bibr9-03000605211017000
bibr6-03000605211017000
Wang X (bibr8-03000605211017000) 2016; 32
Wolfler A (bibr15-03000605211017000) 2010; 76
References_xml – volume: 37
  start-page: 53
  year: 2015
  end-page: 57
  article-title: Opioid receptor A118G polymorphism does not affect the consumption of sufentanil and ropivacaine by patient-controlled epidural analgesia after cesarean section.
  publication-title: Ther Drug Monit
– volume: 76
  start-page: 340
  year: 2010
  end-page: 345
  article-title: Epidural analgesia with ropivacaine and sufentanil is associated with transient fetal heart rate changes
  publication-title: Minerva Anestesiol
– volume: 21
  start-page: 2962
  year: 2015
  end-page: 2965
  article-title: Treatment progress of shivering after cesarean section
  publication-title: Med Recap
– volume: 49
  start-page: 525
  year: 2005
  end-page: 531
  article-title: Epidural ropivacaine 1% with and without sufentanil addition for Caesarean section.
  publication-title: Acta Anaesthesiol Scand
– volume: 32
  start-page: 761
  year: 2016
  end-page: 764
  article-title: Comparison of the efficacy and safety between the use of ropivacaine alone and reopivacaine with sufentanil in epidural labor analgesia
  publication-title: J Clin Anesthesiol
– volume: 5
  start-page: e23565
  year: 2015
  article-title: Effects of Adding Midazolam and Sufentanil to Intrathecal Bupivacaine on Analgesia Quality and Postoperative Complications in Elective Cesarean Section
  publication-title: Anesth Pain Med
– volume: 66
  start-page: 622
  year: 2016
  end-page: 627
  article-title: Associação de sufentanil a dose reduzida de bupivacaína hiperbárica em raquianestesia para cesariana: ensaio clínico randomizado [Sufentanil in combination with low-dose hyperbaric bupivacaine in spinal anesthesia for cesarean section: a randomized clinical trial].
  publication-title: Rev Bras Anestesiol
– volume: 29
  start-page: 752
  year: 2014
  end-page: 758
  article-title: Association of lipophilic opioids and hyperbaric bupivacaine in spinal anesthesia for elective cesarean section. Randomized controlled study
  publication-title: Acta Cir Bras
– volume: 96
  start-page: 1070
  year: 2002
  end-page: 1073
  article-title: A comparison of intrathecal fentanyl and sufentanil for labor analgesia.
  publication-title: Anesthesiology
– volume: 62
  start-page: 676
  year: 2012
  end-page: 684
  article-title: Incidence of shivering after cesarean section under spinal anesthesia with or without intrathecal sufentanil: a randomized study
  publication-title: Rev Bras Anestesiol
– volume: 8
  start-page: 5739
  year: 2015
  end-page: 5745
  article-title: . Hyperbaric spinal anesthesia with ropivacaine coadministered with sufentanil for cesarean delivery: a dose-response study
  publication-title: Int J Clin Exp Med
– volume: 54
  start-page: 284
  year: 2010
  end-page: 290
  article-title: Intrathecal sufentanil decreases the median effective dose (ED50) of intrathecal hyperbaric ropivacaine for cesarean delivery
  publication-title: Acta Anaesthesiol Scand
– volume: 71
  start-page: 93
  year: 2005
  end-page: 100
  article-title: 0.2% ropivacaine with or without sufentanil for patient-controlled epidural analgesia after anterior cruciate ligament repair.
  publication-title: Minerva Anestesiol
– volume: 7
  start-page: e12738
  year: 2017
  article-title: Comparing the Effect of Adding Fentanyl, Sufentanil, and Placebo with Intrathecal Bupivacaine on Duration of Analgesia and Complications of Spinal Anesthesia in Patients Undergoing Cesarean Section
  publication-title: Anesth Pain Med
– volume: 94
  start-page: 680
  year: 2002
  end-page: 685
  article-title: Spinal ropivacaine for caesarean delivery: a comparison of hyberbaric and plain solutions
  publication-title: Anesth Analg
– volume: 10
  start-page: 148
  year: 2015
  end-page: 149
  article-title: Efficacy of small-dosage sufentanil for prevention of shivering and visceral traction pain during selective cesarean delivery.
  publication-title: Guide of China Medicine
– ident: bibr10-03000605211017000
  doi: 10.1097/FTD.0000000000000112
– ident: bibr7-03000605211017000
  doi: 10.1016/S0034-7094(12)70166-6
– volume: 21
  start-page: 2962
  year: 2015
  ident: bibr1-03000605211017000
  publication-title: Med Recap
– volume: 66
  start-page: 622
  year: 2016
  ident: bibr14-03000605211017000
  publication-title: Rev Bras Anestesiol
  doi: 10.1016/j.bjan.2015.05.002
– ident: bibr6-03000605211017000
  doi: 10.4028/www.scientific.net/AMM.740.648
– volume: 71
  start-page: 93
  year: 2005
  ident: bibr11-03000605211017000
  publication-title: Minerva Anestesiol
– volume: 10
  start-page: 148
  year: 2015
  ident: bibr5-03000605211017000
  publication-title: Guide of China Medicine
– ident: bibr9-03000605211017000
  doi: 10.1097/00000539-200203000-00037
– volume: 76
  start-page: 340
  year: 2010
  ident: bibr15-03000605211017000
  publication-title: Minerva Anestesiol
– ident: bibr13-03000605211017000
  doi: 10.5812/aapm.12738
– ident: bibr16-03000605211017000
  doi: 10.5812/aapm.23565
– ident: bibr3-03000605211017000
  doi: 10.1111/j.1399-6576.2004.00580.x
– ident: bibr2-03000605211017000
  doi: 10.1097/00000542-200205000-00007
– volume: 8
  start-page: 5739
  year: 2015
  ident: bibr4-03000605211017000
  publication-title: Int J Clin Exp Med
– volume: 32
  start-page: 761
  year: 2016
  ident: bibr8-03000605211017000
  publication-title: J Clin Anesthesiol
  doi: 10.1016/j.jclinane.2015.11.014
– ident: bibr12-03000605211017000
  doi: 10.1111/j.1399-6576.2009.02051.x
– ident: bibr17-03000605211017000
  doi: 10.1590/S0102-86502014001800010
SSID ssj0042652
Score 2.3228772
Snippet Objective To investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal...
Objective To investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal...
To investigate the efficacy of low-dose sufentanil for preventing shivering and visceral traction pain during cesarean section under spinal...
SourceID doaj
pubmedcentral
proquest
crossref
sage
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 3000605211017000
SubjectTerms Apgar score
Cesarean section
Pain
Prospective Clinical Research Report
SummonAdditionalLinks – databaseName: SAGE Open Access 2014 - NESLI2
  dbid: EF0
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9QwFA7r-uKLeMWuq0SQFWTrtk0ybZ9klR0WQdmHEfat5KoDM-3Qy-r8e89J2xm7qPhW2pQm6UnyJec73yHkdZSDHXCrwpwrG_JYwpWKdehYrA0TPFURRiN__jK7_Mo_XYvrA1KNsTBDDzbvkFYFNfKTNY5uPI0-G5yMZ2CZKCQicPeCAnPR-65dF_1x95hVA--gf7pbo2tbIyFyG47hbXfIXZQuRw7gxTwap25YrcTgdsBsLJEY3KB__ORkIfN6_xOQepti-RtPzC9d8wfk_oA56XlvJA_JgS0fkZOrXrR6e0oX-xis5pSe0Ku9nPX2Mfl5boznddHK0VX1IzRVY2nTOWSdl8sVbStaV5vljdQSICsFFExrFISFRZE2KGuLR4dUlobeQA_hGRht6z6egm7gFdqHSlKYsSRA2JI2nh5WPiGL-cXi42U45GsINcCONuTaGsNzM-PCptBypuNM5RYFF1Mp4pliLjGJcZJr2CRJGUmhcuUcm9k4yyP2lByWVWmfEWozbRxsfIzJFKZIkzZjkdNMGC21yZOARGPfF3rQMseUGqsiHuXLb_-ugLzdvbLphTz-VfgD_tBdQdTg9jeq-lsxDOkCgKbIHcfEJSkHYCQjaL9ymYZJzcBVQI5HcyhGsy4SwQSChjgNyKvd4zV2_wrZzVXnyzAWM9jaBiSdmNGkQtMn5fK7FweH6gDGywLyBg1u_-G_tvXov0s-J_cSZPR4uucxOWzrzr4ASNaql34Y_QLwCjEc
  priority: 102
  providerName: SAGE Publications
Title Addition of low-dose sufentanil to ropivacaine for reducing shivering and visceral traction pain during cesarean section
URI https://journals.sagepub.com/doi/full/10.1177/03000605211017000
https://www.proquest.com/docview/2535036217
https://www.proquest.com/docview/2533313619
https://pubmed.ncbi.nlm.nih.gov/PMC8161908
https://doaj.org/article/43559f4816874240a0cedbf8c196dedb
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9swEBbt9tJL6ZO63QYVyhbKmsqWFNvHbElYCl3CktLcjJ40kNohdvbx7zsjO8lmoe2lF9tYEtZjpJmRP31DyAdWgBwIp-NCaBeLRMGTTkzseWIslyLTDE8jf7sYnn8XX-dyfifUF2LCOnrgruM-gzqXhRcYHgK8OMEUM85qnxsQHQtPuPqygm2dqW4NBrUj0_4fZqBX4oF4RKK3g4R07EALBbL-AwvzPj7yDsgr6J3JU_KkNxjpqKvoM_LAVc_JybRjnL49pbP9AarmlJ7Q6Z6L-vYFuRlZG0BZtPZ0WV_Htm4cbTYeIePVYknbmq7r1eJKGQX2JgUTlq6RzRU0Gm2Qkxb3_aiqLL1aNAY3sGi77g5D0BUUod05RwrLjQL7s6JNwHZVL8lsMp59OY_7YAuxAZuhjQV0qxWFHQrpMmg5N0muC4dsiZmSyVBzn9rUeiUMeDhKMSV1ob3nQ5fkBeOvyFFVV-41oS431oPXYm2uMb6Zcjln3nBpjTK2SCPCtn1fmp6IHONhLMtkyz1-f7gi8mlXZNWxcPwt8xkO6C4jEmiHFyBWZS9W5b_EKiLHW3Eo-1ndlKnkEjV-kkXk_S75F3b_EqHJ9Sbk4Tzh4JdGJDsQo4MKHaZUi5-B2RuqAwZaHpGPKHD7D_-xrW_-R1vfkscpInUCjPOYHLXrjXsHplarB-RhNs8G5NFocvljBvez8cX0chDmGlzHE_YbITcrTQ
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELbQcoAL4ikCCwwSWiS0QUltN8lxQVQFdld7KNLeIj-hUkmqpN3Hv2fGSVq6AsQtip3Wj7Hnm-TzN4y9SQq0A-F0XAjtYpEqvNKpiT1PjeVSZDqh08gnp-PpN_HlXJ73rEo6C9OPYPueaFXYorBZb1Y3KSXxoCEiKXAhbTkM128LiSUEhSbJsAuj45H9FwRKrJLI_ovmH39ixycF6f4dvHmTLfkb5St4ocl9dq-Hj3DUzfcDdstVD9nBWac_fX0Is-1xqvYQDuBsq0x9_YhdHVkbKFpQe1jUl7GtWwft2hOBvJovYFVDUy_nF8ooRJ-AgBYa0nZF_wYtKdTSW0BQlYWLeWvodRasmu5oBCzxEehOPQJuPgrRaAVtYHpVj9ls8mn2cRr3qRdigwhiFQvjrBWFHQvpMuw5N2muC0faiZmS6VhzP7Ij65UwGO8olSipC-09H7s0LxL-hO1VdeWeMnC5sR5jGGtzTdnOlMt54g2X1ihji1HEkmHsS9PLklN2jEWZDkrkN6crYu82jyw7TY5_Vf5AE7qpSHLa4UbdfC_71VkiZpSFF5SDJBOIcVSC_dc-N7g_WbyK2P5gDuVgoeVIckn-P80i9npT_JOGf0FE5Xod6nCecoxSI5btmNFOg3ZLqvmPoPONzUG4lkfsLRnc9o__2tdn_13zFbsznZ0cl8efT78-Z3dHRNQJLM59trdq1u4FIq2VfhmW1C8oKB6L
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Zj9MwELbQIiFeEKcILDBIaJHQhk1iu0kel6NarlUfirRvkc-lUkmqpF3Yf8-Mm7ZkBYg3K7ETH2P7G3vmG8ZeJCXKgXA6LoV2sUgVpnRqYs9TY7kUuU7IG_nL6ejkq_h4Js_6Azfyhel7sHtNZlVYo7BY0-xeWH_U3zEeoWASj4gk5YX45VBlvy5EXgTgOE42KzFuPrK_RaDgKonsbzX_-InBvhTo-weY86rF5G9mX2EnGt9mt3oICcfrMb_Drrn6LjuYrDmoLw9hunOp6g7hACY7durLe-znsbXBTAsaD_PmR2ybzkG38mREXs_msGygbRazC2UUIlBAUAst8bviHgcdsdTSSSCo2sLFrDN0pAXLdu0eAQssAmvPR8AFSCEiraEL1l71fTYdv5--PYn78AuxQRSxjIVx1orSjoR0Obacm7TQpSP-xFzJdKS5z2xmvRIGdR6lEiV1qb3nI5cWZcIfsL26qd1DBq4w1qMeY22hKeKZcgVPvOHSGmVsmUUs2fR9ZXpqcoqQMa_SDRv51eGK2KttkcWal-Nfmd_QgG4zEqV2eNC051U_QyvEjbL0guKQ5AJxjkqw_doXBtcoi6mI7W_EodpIaZVJLgkDpHnEnm9ff6fun5OxcrMKeThPOWqqEcsHYjSo0PBNPfsWuL6xOgjZioi9JIHb_fivbX303zmfsRuTd-Pq84fTT4_ZzYxsdYIh5z7bW7Yr9wTB1lI_DTPqF3vJH6Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Addition+of+low-dose+sufentanil+to+ropivacaine+for+reducing+shivering+and+visceral+traction+pain+during+cesarean+section&rft.jtitle=Journal+of+international+medical+research&rft.au=Chen%2C+Xiao-Rong&rft.au=Gao%2C+Tao&rft.au=Zhang%2C+Yin&rft.au=Peng%2C+Ming-Qing&rft.date=2021-05-01&rft.pub=SAGE+Publications&rft.issn=0300-0605&rft.eissn=1473-2300&rft.volume=49&rft.issue=5&rft_id=info:doi/10.1177%2F03000605211017000&rft_id=info%3Apmid%2F34038198&rft.externalDocID=PMC8161908
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0605&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0605&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0605&client=summon